Previous 10 | Next 10 |
Rockwell's sales are expected to increase significantly in 2021 although the firm is still not profitable. The company recently raised more cash to continue its plan to drive value creation. The firm has a big opportunity with its FPC platform and also in international markets. ...
WIXOM, Mich., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and iron deficiency anemia management and improving...
WIXOM, Mich., Dec. 16, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and iron deficiency anemia management and improving...
Which Penny Stocks Should You Know About Heading Into 2021? As we inch closer to the end of a tumultuous year, there are many penny stocks to watch. During 2020, the COVID pandemic has made several penny stocks jump up greatly in value. While not all penny stocks are correlated with...
Start Time: 16:30 End Time: 17:13 Rockwell Medical, Inc. (RMTI) Q3 2020 Earnings Conference Call November 09, 2020, 16:30 PM ET Company Participants Russell Ellison - President and CEO Russell Skibsted - EVP, CFO and Chief Business Officer Marc Hoffman - CMO Tim Chole - VP, Marketing Claudia ...
Rockwell Medical, Inc. (RMTI) Q2 2020 Earnings Conference Call November 09, 2020 4:20 PM ET Company Participants Claudia Styslinger – Investor Relations Russell Ellison - President, Chief Executive Officer & Director Tim Chole – Vice President, Marketing Russell Skibsted - E...
The following slide deck was published by Rockwell Medical, Inc. in conjunction with their 2020 Q3 earnings call. For further details see: Rockwell Medical, Inc. 2020 Q3 - Results - Earnings Call Presentation
Rockwell Medical (RMTI): Q3 GAAP EPS of -$0.10 in-line.Revenue of $15.28M (-0.8% Y/Y) misses by $0.39M.Cash, equivalents, and investments available-for-sale totaled $67.3M.Expects to commercially launch Triferic AVNU in the United States in Q1 2021; poised to enroll first patie...
- Ended the quarter with $67.3 million in cash, cash equivalents and investments- - Q 3 2020 revenue of $ 15.3 million - - U.S. commercial launch of Triferic ® AVNU expected in Q1 2021 - ...
WIXOM, Mich., Oct. 27, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) ("Rockwell Medical" or the “Company”), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and iron deficiency anemia management and improving outcomes for ...
News, Short Squeeze, Breakout and More Instantly...
Rockwell Medical Inc. Company Name:
RMTI Stock Symbol:
NASDAQ Market:
Rockwell Medical Inc. Website:
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, announced that the Company's President and Chief Executive Officer, Dr. Mark Strobeck ...
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that it will release its financial and operational results for the second ...
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that Tim Chole was promoted to Chief Commercial Officer, reporting to the ...